Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Gottlieb Becomes FDA Commissioner With Immediate Issues Pending

May 10 2017

• By Derrick Gingery and Sue Darcey

Related Content

Califf Maintains Desire To Stay At FDA, But Would Either Presidential Candidate Keep Him?

Nov 05 2016

US FDA Gains Budget Increase In FY 2017…And Not Through Fees

May 01 2017

Will Senate User-Fee Package Be Smooth Sailing Despite Add-Ons?

May 09 2017

Ostroff: Administration Coming Up To Speed On Planned FDA Guidances

May 04 2017

FDA Nominee Gottlieb's Recusals Span Clinical Decision Software Firms, Imaging Centers, Drug Makers

Apr 04 2017

Gottlieb Touts Devices For Pain Control To Help Solve Opioid Crisis

Apr 06 2017

Trump's Budget Outline Threatens User Fee Agreements

Mar 17 2017

FDA's Next Commissioner: Will Trump Follow Hamburg Or McClellan 'Schedule'?

Jan 31 2017

Related Companies

Nevro Corp.

Additional Topics

United States Regulation Legislation Leadership Medical Device

More from Regulation

More from Policy & Regulation

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window